Cargando…

High‐Intensity Statin Reduces the Risk of Mortality Among Chronic Liver Disease Patients With Atherosclerotic Cardiovascular Disease: A Population‐Based Cohort Study

BACKGROUND: 2018 American Heart Association/American College of Cardiology cholesterol guideline recommends statin in patients with chronic and/or stable liver disease for secondary prevention of atherosclerotic cardiovascular disease yet remains equivocal on the adequate intensity of statin for pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bea, Sungho, Oh, In‐Sun, Kim, Ju Hwan, Sinn, Dong Hyun, Chang, Yoosoo, Ryu, Seungho, Shin, Ju‐Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227280/ https://www.ncbi.nlm.nih.gov/pubmed/37066797 http://dx.doi.org/10.1161/JAHA.122.028310

Ejemplares similares

Hearing Loss and Risk of Overall, Injury-Related, and Cardiovascular Mortality: The Kangbuk Samsung Health Study
por: Lee, Woncheol, et al.
Publicado: (2020)

Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases
por: Lee, Myunhee, et al.
Publicado: (2023)

Do statins benefit low-risk population for primary prevention of atherosclerotic cardiovascular disease: A retrospective cohort study
por: Ryou, In Sun, et al.
Publicado: (2022)

Antioxidant Effects of Statins in Patients with Atherosclerotic Cerebrovascular Disease
por: Moon, Gyeong Joon, et al.
Publicado: (2014)

Statin Use for Atherosclerotic Cardiovascular Disease Prevention Among Sexual Minority Adults
por: Guo, Yi, et al.
Publicado: (2020)

The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis
por: Chidambaram, Vignesh, et al.
Publicado: (2021)

Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
por: Li, Yi-Heng, et al.
Publicado: (2020)

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

The Prevalence of Potential Prescribing Omissions for Antiplatelets and Statins in Older Adults With Atherosclerotic Cardiovascular Disease
por: Alshehri, Samah, et al.
Publicado: (2023)

Erratum: Environmental Heavy Metal Exposure and Chronic Kidney Disease in the General Population
por: Kim, Nam Hee, et al.
Publicado: (2015)

Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
por: Kao, Yu-Cheng, et al.
Publicado: (2021)

Underuse of statins for secondary prevention of atherosclerotic cardiovascular disease events among ambulatory surgical patients
por: Schonberger, Robert B., et al.
Publicado: (2020)

Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study
por: Kim, Seolhye, et al.
Publicado: (2017)

Atherosclerotic Cardiovascular Disease Events in Adults With CKD Taking a Moderate- or High-Intensity Statin: The Chronic Renal Insufficiency Cohort (CRIC) Study
por: Poudel, Bharat, et al.
Publicado: (2021)

Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost‐effectiveness analysis
por: Boettiger, David C, et al.
Publicado: (2020)

Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation
por: Oh, Minyoung, et al.
Publicado: (2021)

Cardiovascular Health Metrics in the Development and Regression of Nonalcoholic Fatty Liver Disease: A Cohort Study
por: Jang, Eun-Hee, et al.
Publicado: (2019)

Low-level alcohol consumption and cancer mortality
por: Ko, Hyeonyoung, et al.
Publicado: (2021)

Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016
por: Yao, Xiaoxi, et al.
Publicado: (2020)

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States
por: Boettiger, David C, et al.
Publicado: (2021)

Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen
por: Al-Ashwal, Fahmi Y., et al.
Publicado: (2022)

Trends and outcome of statin therapy in dialysis patients with atherosclerotic cardiovascular diseases: A population-based cohort study
por: Lee, Myunhee, et al.
Publicado: (2023)

Inflammation in atherosclerotic cardiovascular disease
por: Shah, Prediman K., et al.
Publicado: (2019)

Environmental Heavy Metal Exposure and Chronic Kidney Disease in the General Population
por: Kim, Nam Hee, et al.
Publicado: (2015)

Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? ‒ Data from a multicenter registry cohort study in Taiwan
por: Yeh, Yen-Ting, et al.
Publicado: (2017)

Trajectory of Smoking and Incidence of Atherosclerotic Cardiovascular Disease among Korean Young Adult Men
por: Jee, Yongho, et al.
Publicado: (2019)

Self-reported and cotinine-verified smoking and increased risk of incident hearing loss
por: Lee, Woncheol, et al.
Publicado: (2021)

Impact of Self-Rated Health on Progression to a Metabolically Unhealthy Phenotype in Metabolically Healthy Obese and Non-Obese Individuals
por: Kim, Mi-Hyun, et al.
Publicado: (2019)

Depressive symptoms and risk of liver-related mortality in individuals with hepatitis B virus infection: a cohort study
por: Cho, In Young, et al.
Publicado: (2020)

Statins; the panacea of cardiovascular disease
por: de Waard, G. A., et al.
Publicado: (2017)

Plasma Aldosterone Concentration as a Determinant for Statin Use among Middle-Aged Hypertensive Patients for Atherosclerotic Cardiovascular Disease
por: Lin, Jui-Hsiang, et al.
Publicado: (2018)

Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease
por: Wang, Miao, et al.
Publicado: (2020)

Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System
por: Dorsch, Michael P., et al.
Publicado: (2019)

Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis
por: Boettiger, David C., et al.
Publicado: (2021)

Using deep learning-based natural language processing to identify reasons for statin nonuse in patients with atherosclerotic cardiovascular disease
por: Sarraju, Ashish, et al.
Publicado: (2022)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk
por: Zheutlin, Alexander R., et al.
Publicado: (2022)

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States
por: Hammond, Michael M., et al.
Publicado: (2023)

The Effects of Urinary Albumin and Hypertension on All-Cause and Cardiovascular Disease Mortality in Korea
por: Seo, Mi Hae, et al.
Publicado: (2017)

Risk factors for incident anemia of chronic diseases: A cohort study
por: Lee, Yun-Gyoo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rht6e5rjv5vcc6mpe6d5uvv6p3